Jones, Steven Huntley and Knowles, Dawn and Tyler, Elizabeth and Holland, Fiona and Peters, Sarah and Lobban, Anne Fiona and Langshaw, Brian and Hilton, Claire Alexandra and Long, Rita Marie and Gantt, Kay and Owen, Rebecca Louise and Roberts, Christopher and Riste, Lisa Kate (2018) The feasibility and acceptability of a novel anxiety in bipolar disorder intervention compared to treatment as usual : a randomized controlled trial. Depression and Anxiety, 35 (10). pp. 953-965. ISSN 1091-4269
Anxiety_outcome_paper_plain_text_revision_clean_01.05.18.pdf - Accepted Version
Available under License Creative Commons Attribution-NonCommercial.
Download (893kB)
Abstract
1 Background Comorbid anxiety is common in bipolar disorder (BD) and associated with worse clinical outcomes including increased suicidality. Despite effective psychological treatments for anxiety, research into treating anxiety in BD is underdeveloped. This paper describes a novel psychological intervention to address anxiety in context of bipolar disorder (AIBD). 2 Methods Adults with BD and clinically significant anxiety symptoms were randomized to AIBD plus treatment as usual (TAU) or TAU alone. AIBD offered 10 sessions of psychological therapy using a formulation‐based approach. Feasibility and acceptability were evaluated through recruitment, retention, therapy attendance, alliance, fidelity, and qualitative feedback. Clinical outcomes were assessed at baseline, 16, 48, and 80 weeks: interim assessments of relapse at 32 and 64 weeks. 3 Results Seventy‐two participants were recruited with 88% retention to 16 weeks and 74% to 80 weeks (similar between arms). Therapy participants attended urn:x-wiley:10914269:media:da22781:da22781-math-00017.7 (SD 2.8) sessions. Therapeutic alliance and therapy fidelity were acceptable. Qualitative interviews indicated that participants valued integrated support for anxiety with BD and coping strategies. Some suggested a longer intervention period. Clinical outcomes were not significantly different between arms up to 80 weeks follow‐up. 4 Conclusions AIBD is feasible and acceptable but lack of impact on clinical outcomes indicates that adaptations are required. These are discussed in relation to qualitative feedback and recent literature published since the trial completed.